BioCentury | Sep 21, 2018
Financial News

uBiome moving into therapeutics with $83M series C

...development using its patented microbiome assets. Also participating in the round were 8VC, Y Combinator, Dentsu Ventures...
BioCentury | Sep 21, 2018
Finance

A bigger ‘biome

...the round, which also saw participation from existing investors 8VC and Y Combinator, new investor Dentsu Ventures...
BioCentury | Sep 21, 2018
Financial News

uBiome moving into therapeutics with $83M series C

...development using its patented microbiome assets. Also participating in the round were 8VC, Y Combinator, Dentsu Ventures...
BioCentury | Jul 13, 2018
Financial News

Cue Health raises $45M series B

...million in a series B round from new investors Johnson & Johnson Innovation, Section 32, Dentsu Ventures...
Items per page:
1 - 4 of 4
BioCentury | Sep 21, 2018
Financial News

uBiome moving into therapeutics with $83M series C

...development using its patented microbiome assets. Also participating in the round were 8VC, Y Combinator, Dentsu Ventures...
BioCentury | Sep 21, 2018
Finance

A bigger ‘biome

...the round, which also saw participation from existing investors 8VC and Y Combinator, new investor Dentsu Ventures...
BioCentury | Sep 21, 2018
Financial News

uBiome moving into therapeutics with $83M series C

...development using its patented microbiome assets. Also participating in the round were 8VC, Y Combinator, Dentsu Ventures...
BioCentury | Jul 13, 2018
Financial News

Cue Health raises $45M series B

...million in a series B round from new investors Johnson & Johnson Innovation, Section 32, Dentsu Ventures...
Items per page:
1 - 4 of 4